Cargando…
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan
Raloxifene was approved for chemoprevention against breast cancer among high-risk women in addition to tamoxifen by the US Food and Drug Administration. This study aims to evaluate cost-effectiveness of these agents under Japan's health system. A cost-effectiveness analysis with Markov model co...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634700/ https://www.ncbi.nlm.nih.gov/pubmed/19142182 http://dx.doi.org/10.1038/sj.bjc.6604869 |